Summary

96.73 -4.01(-3.98%)09/06/2024
Axcelis Technologies Inc (ACLS)

Key Facts


1 Day1 Week1 Month3 Months6 Months1 Year5 YearsAll Time
-3.87-11.52-9.67-24.07-14.56-49.37504.561.02


Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1


Trading Data
Close96.73
Open100.68
High100.87
Low95.91
Volume467,300
Change-3.89
Change %-3.87
Avg Volume (20 Days)373,491
Volume/Avg Volume (20 Days) Ratio1.25
52 Week Range93.77 - 196.03
Price vs 52 Week High-50.66%
Price vs 52 Week Low3.16%
Range-3.92
Gap Up/Down-1.37
Fundamentals
Market Capitalization (Mln)3,286
EBIDTA279,120,992
PE Ratio15.0317
PEG Ratio1.2300
WallStreet Target Price144.00
Book Value27.6570
Earnings Per Share7.5700
EPS Estimate Current Quarter1.2400
EPS Estimate Next Quarter1.4900
EPS Estimate Current Year6.3300
EPS Estimate Next Year8.1000
Diluted EPS (TTM)7.5700
Revenues
Profit Marging0.2216
Operating Marging (TTM)0.2240
Return on asset (TTM)0.1419
Return on equity (TTM)0.3120
Revenue TTM1,128,956,032
Revenue per share TTM34.4910
Quarterly Revenue Growth (YOY)-0.0060
Quarterly Earnings Growth (YOY)0.0980
Gross Profit (TTM)401,790,000
Dividends
Dividend Share0.0000
Dividend Yield
Valuations
Trailing PE15.0317
Forward PE14.6199
Price Sales (TTM)0.0000
Price Book (MRQ)3.9427
Revenue Enterprise Value 2.6083
EBITDA Enterprise Value9.9287
Shares
Shares Outstanding32,532,500
Shares Float32,126,492
Shares Short0
Shares Short (Prior Month)0
Shares Ratio0.00
Short Outstanding (%)0.00
Short Float (%)0.09
Insider (%)1.08
Institutions (%)95.40


09/04 08:00 EST - prnewswire.com
Axcelis Announces Sponsorship and Participation in The International Conference on Ion Implantation Technology 2024 in Toyoma, Japan
BEVERLY, Mass. , Sept. 4, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a top-level Platinum Sponsor at the International Conference on Ion Implantation Technology 2024 (IIT 2024) taking place September 23-26 at the Toyama International Conference Center in Japan.
08/30 10:31 EST - zacks.com
Axcelis Stock Plunges 16% YTD: Should You Buy, Hold or Sell?
ACLS' performance is bearing the brunt of softness in the memory market. It notes that demand may moderate in the General Mature in the second half of 2024.
08/29 08:00 EST - prnewswire.com
Axcelis Announces Participation in SEMICON India 2024
Showcase Features the Purion and GSD Ovation Series of Ion Implanters Designed to Deliver Significant Technology and Manufacturing Advantages BEVERLY, Mass. , Aug. 29, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its Purion™ and GSD Ovation™ Series of ion implanters at the inaugural SEMICON India 2024, India's premier semiconductor event.
08/29 06:05 EST - zacks.com
New Strong Sell Stocks for August 29th
BLMN, ACLS and AIQUY have been added to the Zacks Rank #5 (Strong Sell) List on August 29, 2024.
08/28 04:55 EST - fool.com
2 EV Chip Stocks Down 34% and 45% That Could Become Stealth Artificial Intelligence (AI) Plays
On Semi and Axcelis are leaders in the silicon carbide ecosystem. SiC chips are set for strong growth because of increasing use in electric vehicles.
08/14 09:15 EST - investorplace.com
3 Stocks to Sell Now Before the Bear Market Hits
In today's unpredictable stock market, investors must discern which stocks to sell to protect their portfolios. The focus here is on three companies facing significant challenges that suggest they may be candidates for the stocks to sell list.
08/13 08:00 EST - zacks.com
New Strong Sell Stocks for August 13th
ADM, ACLS and CVS have been added to the Zacks Rank #5 (Strong Sell) List on August 13, 2024.
08/08 08:00 EST - prnewswire.com
Axcelis Announces Participation in Upcoming Investor Conferences
BEVERLY, Mass. , Aug. 8, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences, at which management will be available for one-on-ones and small group meetings.
08/08 05:53 EST - fool.com
S&P 500 Sell-Off: 1 Bargain-Basement Semiconductor Stock to Buy Right Now
The S&P 500 had a smooth run higher during the first half of 2024, but it's now facing a pullback. Market corrections give investors an opportunity to buy quality stocks at a discount.
08/02 11:46 EST - zacks.com
Axcelis' (ACLS) Q2 Earnings and Revenues Surpass Estimates
Axcelis Technologies ACLS reported second-quarter 2024 non-GAAP earnings per share (EPS) of $1.55, which surpassed the Zacks Consensus Estimate by 11.5%. However, the bottom line decreased 16.7% year over year.
08/01 12:24 EST - seekingalpha.com
Axcelis Technologies, Inc. (ACLS) Q2 2024 Earnings Call Transcript
Axcelis Technologies, Inc. (NASDAQ:ACLS ) Q2 2024 Earnings Conference Call August 1, 2024 8:30 AM ET Company Participants David Ryzhik - Senior Vice President of Investor Relations and Corporate Strategy Russell Low - President and Chief Executive Officer James Coogan - Executive Vice President and Chief Financial Officer Conference Call Participants Jed Dorsheimer - William Blair Tom Diffely - D.A. Davidson and Company Craig Ellis - B.
07/31 18:46 EST - zacks.com
Axcelis Technologies (ACLS) Q2 Earnings and Revenues Beat Estimates
Axcelis Technologies (ACLS) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.86 per share a year ago.
07/31 16:01 EST - prnewswire.com
Axcelis Announces Financial Results for Second Quarter 2024
Revenue of $256.5 million Operating margin of 20.6% Diluted earnings per share of $1.55 BEVERLY, Mass. , July 31, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS) today announced financial results for the second quarter ended June 30, 2024.
07/29 09:15 EST - zacks.com
Factors to Note Ahead of Axcelis' (ACLS) Q2 Earnings Release
Axcelis' (ACLS) second-quarter performance is likely to have benefited from increasing demand for the Purion suite of products.
07/24 11:07 EST - zacks.com
Axcelis Technologies (ACLS) Expected to Beat Earnings Estimates: Should You Buy?
Axcelis (ACLS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
07/23 10:56 EST - zacks.com
Does Axcelis (ACLS) Have the Potential to Rally 28.41% as Wall Street Analysts Expect?
The average of price targets set by Wall Street analysts indicates a potential upside of 28.4% in Axcelis (ACLS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
07/17 16:01 EST - prnewswire.com
Axcelis Announces Timing and Availability of Second Quarter 2024 Results and Conference Call
BEVERLY, Mass. , July 17, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the second quarter 2024 on Wednesday, July 31, 2024, at 4:00 p.m.
07/15 07:22 EST - benzinga.com
This Analyst With 87% Accuracy Rate Sees More Than 12% Upside In AMD - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts
U.S. stocks closed higher on Friday, with the Dow Jones index topping the key 40,000 mark during the session. The 30-stock blue-chip index gained around 1.6% last week.
07/10 13:11 EST - zacks.com
Will Axcelis (ACLS) Beat Estimates Again in Its Next Earnings Report?
Axcelis (ACLS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
07/10 10:55 EST - zacks.com
Axcelis Technologies (ACLS) Just Flashed Golden Cross Signal: Do You Buy?
Axcelis Technologies, Inc. (ACLS) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ACLS's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.